Why aren’t cytogenetic analyses being implemented into clinical studies of CLL?
Overcoming the shortfalls of ibrutinib with fludarabine in CLL patientss
Inhye Ahn • 12 May 2017
Enhancing autologous cellular therapy with ibrutinib in CLL patients
Iris de Weerdt • 12 May 2017